Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians.


BACKGROUND There is little published information on baseline characteristics and therapeutic outcomes in hepatitis C virus (HCV)-infected Aboriginal Canadians. It is unclear what proportion of HCV-infected Aboriginal people receive therapy relative to other populations. METHODS Adults with chronic HCV infection, quantifiable serum HCV-RNA levels and… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics